journal article·2015-01-27

Elucidating the Fundamental Mechanisms of Cell Death Triggered by Photothermal Therapy

Jilian R. Melamed, Rachel S. Edelstein, Emily S. Day

ACS Nano· Volume 9· Issue 1
Publisher page

Abstract

Photothermal therapy (PTT) utilizes nanoparticles embedded within tumors as exogenous energy absorbers to convert laser light energy into heat to ablate cancer cells. While PTT is a promising alternative to conventional cancer therapy, under certain irradiation conditions, it can produce cellular necrosis, and this necrosis may lead to pro-inflammatory responses that are detrimental to treatment success. Recent studies have shown that PTT can be modulated to induce apoptosis rather than necrosis, which is appealing since apoptosis discourages an inflammatory response. In this issue of ACS Nano, del Pino, Pardo, de la Fuente, and colleagues reveal the intracellular signaling cascades involved in the apoptotic response to PTT using cells harboring photothermal transducing nanoprisms. In this Perspective, we present an overview of nanoparticle-mediated PTT and discuss photothermally induced apoptosis as a potential therapeutic pathway.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Extracellular vesicles in disease · Photoacoustic and Ultrasonic Imaging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Biomedical Engineering, University of Delaware, Newark, Delaware 19716, United States

References (18)

Show source-provided references
1. Jain R. K. · Nat. Rev. Clin. Oncol. · 2010 · 7 · 65310.1038/nrclinonc.2010.139 ↗
2. Hirsch L. R. · Proc. Natl. Acad. Sci. U.S.A. · 2003 · 100 · 1354910.1073/pnas.2232479100 ↗
3. Day E. · J. Neuro-Oncol. · 2011 · 104 · 5510.1007/s11060-010-0470-8 ↗
4. Day E. S. · Nanomedicine · 2012 · 7 · 113310.2217/nnm.11.189 ↗
5. Dickerson E. B. · Cancer Lett. · 2008 · 269 · 5710.1016/j.canlet.2008.04.026 ↗
6. Chen J. · Small · 2010 · 6 · 81110.1002/smll.200902216 ↗
7. Nanospectra Biosciences, Inc. Pilot Study of AuroLase Therapy in Refractory and/or Recurrent Tumors of the Head and Neck. In ClinicalTrials.gov [Internet]; National Library of Medicine:Bethesda, MD, 2000, (cited 2014 Dec 20). Available fromhttps://clinicaltrials.gov/ct2/show/NCT00848042; NLM identifier: NCT00848042.
8. Nanospectra Biosciences, Inc.Efficacy Study of AuroLase Therapy in Subjects with Primary and/or Metastatic Lung Tumors. In ClinicalTrials.gov [Internet];National Library of Medicine:Bethesda, MD, 2000, [cited 2014 Dec 20]. Available fromhttps://clinicaltrials.gov/ct2/show/NCT01679470; NLM Identifier: NCT01679470.
9. 10.1021/nn505468v10.1021/nn505468v ↗
10. Martin S. J. · Mol. Cell · 2012 · 46 · 38710.1016/j.molcel.2012.04.026 ↗
11. Mocan T. · J. Cancer · 2014 · 5 · 67910.7150/jca.9481 ↗
12. Huang X. · J. Biomed. Opt. · 2010 · 15 · 05800210.1117/1.3486538 ↗
13. Tong L. · Nanomedicine · 2009 · 4 · 26510.2217/nnm.09.4 ↗
14. Li J.-L. · Biomaterials · 2010 · 31 · 949210.1016/j.biomaterials.2010.08.068 ↗
15. Pelaz B. · Langmuir · 2012 · 28 · 896510.1021/la204712u ↗
16. Cirman T. · J. Biol. Chem. · 2004 · 279 · 357810.1074/jbc.M308347200 ↗
17. Jensen S. A. · Sci. Transl. Med. · 2013 · 5 · 209ra15210.1126/scitranslmed.3006839 ↗
18. Deng Z. J. · ACS Nano · 2013 · 7 · 957110.1021/nn4047925 ↗